Cakir, C., Kuspinar, G., Aslan, K., Bozyigit, C., Kasapoglu, I., Dirican, M., Uncu, G., & Avci, B. (2024) Dehydroepiandrosterone modulates the PTEN/PI3K/AKT signaling pathway to alleviate 4-vinylcyclohexene diepoxide-induced premature ovarian insufficiency in rats, Experimental Animals.
Disclaimer: Information provided it this page is for general information only and does not substitute for professional medical advice.
For detailed information about DHEA 300 by Euro-Pharmacies, consult with your doctor or healthcare professional.
Cakir, C., Kuspinar, G., Aslan, K., Bozyigit, C., Kasapoglu, I., Dirican, M., Uncu, G., & Avci, B. (2024) Dehydroepiandrosterone modulates the PTEN/PI3K/AKT signaling pathway to alleviate 4-vinylcyclohexene diepoxide-induced premature ovarian insufficiency in rats, Experimental Animals.
Cakir, C., Kuspinar, G., Aslan, K., Bozyigit, C., Kasapoglu, I., Dirican, M., Uncu, G., & Avci, B. (2024) Dehydroepiandrosterone modulates the PTEN/PI3K/AKT signaling pathway to alleviate 4-vinylcyclohexene diepoxide-induced premature ovarian insufficiency in rats, Experimental Animals.
Cakir, C., Kuspinar, G., Aslan, K., Bozyigit, C., Kasapoglu, I., Dirican, M., Uncu, G., & Avci, B. (2024) Dehydroepiandrosterone modulates the PTEN/PI3K/AKT signaling pathway to alleviate 4-vinylcyclohexene diepoxide-induced premature ovarian insufficiency in rats, Experimental Animals.